相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Radioactive Iodine Therapy in Patients With Thyroid Carcinoma With Distant Metastases: A SEER-Based Study
Chenyuan Li et al.
CANCER CONTROL (2020)
Vemurafenib Redifferentiation of BRAF Mutant, RAI-Refractory Thyroid Cancers
Lara A. Dunn et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Controversies, Consensus, and Collaboration in the Use of 131I Therapy in Differentiated Thyroid Cancer: A Joint Statement from the American Thyroid Association, the European Association of Nuclear Medicine, the Society of Nuclear Medicine and Molecular Imaging, and the European Thyroid Association
R. Michael Tuttle et al.
THYROID (2019)
DOES T STAGE AFFECT PROGNOSIS IN PATIENTS WITH STAGE IV B DIFFERENTIATED THYROID CANCER?
Mu Li et al.
ENDOCRINE PRACTICE (2019)
Thyroid Cancer Bone Metastasis Survival and Genomic Characteristics of a Large Tertiary Care Cohort
Jessica D. Kondraciuk et al.
CLINICAL NUCLEAR MEDICINE (2019)
Mitogen-Activated Protein Kinase Pathway Inhibition for Redifferentiation of Radioiodine Refractory Differentiated Thyroid Cancer: An Evolving Protocol
Amir Iravani et al.
THYROID (2019)
2019 European Thyroid Association Guidelines for the Treatment and Follow-Up of Advanced Radioiodine-Refractory Thyroid Cancer
Laura Fugazzola et al.
EUROPEAN THYROID JOURNAL (2019)
Bone Metastases from Thyroid Carcinoma of Follicular Origin: A Single Institutional Experience
Claudia Matta-Coelho et al.
EUROPEAN THYROID JOURNAL (2019)
Treatment of refractory thyroid cancer
Amandine Berdelou et al.
ENDOCRINE-RELATED CANCER (2018)
Follicular thyroid cancer and Hurthle cell carcinoma: challenges in diagnosis, treatment, and clinical management
Giorgio Grani et al.
LANCET DIABETES & ENDOCRINOLOGY (2018)
Co-existence of BRAFV600E and TERT promoter mutations in papillary thyroid carcinoma is associated with tumor aggressiveness, but not with lymph node metastasis
Haoyu Ren et al.
CANCER MANAGEMENT AND RESEARCH (2018)
Differentiated thyroid cancer theranostics: radioiodine and beyond
Partha S. Choudhury et al.
BRITISH JOURNAL OF RADIOLOGY (2018)
Real-life management and outcome of thyroid carcinoma-related bone metastases: results from a nationwide multicenter experience
G. Mazziotti et al.
ENDOCRINE (2018)
Comparison of Empiric Versus Whole-Body/-Blood Clearance Dosimetry Based Approach to Radioactive Iodine Treatment in Patients with Metastases from Differentiated Thyroid Cancer
Desiree Deandreis et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
Systematic review of site distribution of bone metastases in differentiated thyroid cancer
Marcela Osorio et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2017)
Extrathyroidal Extension Is Associated with Compromised Survival in Patients with Thyroid Cancer
Linda M. Youngwirth et al.
THYROID (2017)
Long-term follow-up of papillary and follicular thyroid carcinomas with bone metastasis
Jen-Der Lin et al.
PLoS One (2017)
Early prognostic factors at the time of diagnosis of bone metastasis in patients with bone metastases of differentiated thyroid carcinoma
Yun Mi Choi et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2016)
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
Bryan R. Haugen et al.
THYROID (2016)
The number of 131I therapy courses needed to achieve complete remission is an indicator of prognosis in patients with differentiated thyroid carcinoma
Elena-Daphne Thies et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2014)
Tree-Based Model for Thyroid Cancer Prognostication
Mousumi Banerjee et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
TERT Promoter Mutations Are a Major Indicator of Poor Outcome in Differentiated Thyroid Carcinomas
Miguel Melo et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
A Japanese family with nonautoimmune hyperthyroidism caused by a novel heterozygous thyrotropin receptor gene mutation
Akie Nakamura et al.
PEDIATRIC RESEARCH (2014)
Natural history of small radioiodine-avid bone metastases that have no structural correlate on imaging studies
Eyal Robenshtok et al.
ENDOCRINE (2014)
Evaluating the Prognostic Factors Associated with Cancer-specific Survival of Differentiated Thyroid Carcinoma Presenting with Distant Metastasis
Brian Hung-Hin Lang et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
Prognostic Implications of Radioiodine Avidity and Serum Thyroglobulin in Differentiated Thyroid Carcinoma with Distant Metastasis
Hye Jeong Kim et al.
WORLD JOURNAL OF SURGERY (2013)
Skeletal-Related Events due to Bone Metastases from Differentiated Thyroid Cancer
Azeez Farooki et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
The Impact of Distant Metastases at Presentation on Prognosis in Patients with Differentiated Carcinoma of the Thyroid Gland
Iain J. Nixon et al.
THYROID (2012)
Cancer Response Criteria and Bone Metastases: RECIST 1.1, MDA and PERCIST
Colleen M. Costelloe et al.
Journal of Cancer (2012)
Do histological, immunohistochemical, and metabolic (radioiodine and fluorodeoxyglucose uptakes) patterns of metastatic thyroid cancer correlate with patient outcome?
D. Deandreis et al.
ENDOCRINE-RELATED CANCER (2011)
Efficacy and Survival Analysis of 131I Therapy for Bone Metastases from Differentiated Thyroid Cancer
Zhong-Ling Qiu et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Approach to the Thyroid Cancer Patient with Bone Metastases
Jason A. Wexler
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Differentiated Thyroid Carcinoma Presenting With Distant Metastasis at Initial Diagnosis Clinical Outcomes and Prognostic Factors
Jandee Lee et al.
ANNALS OF SURGERY (2010)
Prognostic factors and the therapeutic strategy for patients with bone metastasis from differentiated thyroid carcinoma
Yorihisa Orita et al.
SURGERY (2010)
The Importance of Age over Radioiodine Avidity as a Prognostic Factor in Differentiated Thyroid Carcinoma with Distant Metastases
Jasna Mihailovic et al.
THYROID (2009)
Bone metastases from differentiated thyroid carcinoma
M. M. Muresan et al.
ENDOCRINE-RELATED CANCER (2008)
Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis
Elliot Sampson et al.
CANCER (2007)
Staging systems for papillary thyroid carcinoma - A review and comparison
Brian Hung-Hin Lang et al.
ANNALS OF SURGERY (2007)
Clinical features of metastatic bone disease and risk of skeletal morbidity
Robert E. Coleman
CLINICAL CANCER RESEARCH (2006)
Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: Benefits and limits of radioiodine therapy
C. Durante et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Differentiated thyroid carcinoma with distant metastases at presentation: prognostic factors and outcome
M Haq et al.
CLINICAL ENDOCRINOLOGY (2005)
Iodine-131 treatment and high-resolution CT: results in patients with lung metastases from differentiated thyroid carcinoma
S Ilgan et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2004)
Outcome after radioiodine therapy in 107 patients with differentiated thyroid carcinoma and initial bone metastases: side-effects and influence of age
T Petrich et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE (2001)
Bone metastases from thyroid carcinoma: Clinical characteristics and prognostic variables in one hundred forty-six patients
AG Pittas et al.
THYROID (2000)
分享论文
